Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease

Continuous dopaminergic stimulation in Parkinson’s disease (PD) has several advantages over pulsatile, non-continuous, stimulation. These therapies currently consist of pump-based and transcutaneous therapies and are based on a more constant delivery of the dopaminergic drug resulting in continuous...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wamelen, Daniel J., Grigoriou, Sotirios, Chaudhuri, K. Ray, Odin, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311379/
https://www.ncbi.nlm.nih.gov/pubmed/30584160
http://dx.doi.org/10.3233/JPD-181476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311379/
https://www.ncbi.nlm.nih.gov/pubmed/30584160
http://dx.doi.org/10.3233/JPD-181476

Ejemplares similares